Biotech Company With Clinical Operations Developing Psychedelic Medicine To Treat Addiction

First 3 UK Clinics Opened In 2021, Targeting 20 Clinics By 2024 ~$100M In Revenue

Free
Discussion Forum: Awakn Life Sciences Corp.
List Message View
Thread Message View
New Message
Message Title
Rating
Author / Date
Icon agoracom END OF DAY ALERT: Awakn Life Sciences (AWKN: NEO) (AWKNF: OTCQB) Up 18% On 23K SHARES

AGORACOM-NR
Jul 04, 2022 04:00PM
Re: Awakn Life Sciences to Participate in Upcoming May 2022 Conferences

hgriffin08
Jun 22, 2022 11:20AM
Icon agoracom Awakn Life Sciences to Present in Upcoming June 2022 Conferences

AGORACOM-NR
Jun 17, 2022 09:03AM
Icon agoracom END OF DAY ALERT: Awakn Life Sciences (AWKN: NEO) (AWKNF: OTCQB) Up 29% On 81K SHARES

AGORACOM-NR
Jun 15, 2022 04:00PM
Icon agoracom Awakn Life Sciences Reports Results for Quarter Ended April 30, 2022

AGORACOM-NR
Jun 14, 2022 04:00PM
Icon agoracom Awakn Life Sciences Appoints Biotech and Investment Veteran Dennis Purcell as a Special Advisor to the CEO

AGORACOM-NR
Jun 07, 2022 07:30AM
Icon agoracom Awakn Life Sciences Initiates Follow-On Behavioral Study to Focus on Gambling Disorder

AGORACOM-NR
Jun 02, 2022 07:30AM
Re: Awakn Life Sciences Provides Shareholder Update on Three Operational Ketamine-Assisted Therapy Clinics in the UK and Norway

run3donlineaz
Jun 01, 2022 05:46AM
Re: Awakn Life Sciences to Participate in Upcoming May 2022 Conferences

run3donlineaz
Jun 01, 2022 05:45AM
Icon agoracom Awakn Life Sciences Files Patent Cooperation Treaty (PCT) Application for the Treatment of Behavioral Addictions

AGORACOM-NR
May 26, 2022 07:30AM
Icon agoracom Awakn Life Sciences CEO, Anthony Tennyson, Joins Dustin Robinson of Iter Investments for 'The Investor Hotseat' via Live Stream on May 26th

AGORACOM-NR
May 24, 2022 07:30AM
Icon agoracom Awakn Life Sciences Completes World's First Ketamine Treatment Study for a Range of Behavioral Addictions

AGORACOM-NR
May 19, 2022 07:56AM
Icon agoracom Awakn Life Sciences Appoints UK Leader in Addictions Psychiatry, Dr. Arun Dhandayudham, as Chief Medical Officer

AGORACOM-NR
May 17, 2022 07:30AM
Icon agoracom Awakn Life Sciences to Participate in Upcoming May 2022 Conferences

AGORACOM-NR
May 05, 2022 07:30AM
Icon agoracom Awakn Life Sciences Reports Fiscal Fourth Quarter and Fiscal Year January 31, 2022, Results

AGORACOM-NR
Apr 28, 2022 04:28PM
Icon agoracom Awakn Life Sciences Provides Shareholder Update on Three Operational Ketamine-Assisted Therapy Clinics in the UK and Norway

AGORACOM-NR
Apr 13, 2022 07:30AM
Icon agoracom Awakn Successfully Completes Phase One of Its Drug Discovery Program

AGORACOM-NR
Apr 06, 2022 07:30AM
Icon agoracom Awakn Life Sciences to Participate in Upcoming April 2022 Conferences

AGORACOM-NR
Apr 05, 2022 07:30AM
Icon agoracom Awakn Life Sciences Announces Closing of Private Placement

AGORACOM-NR
Mar 22, 2022 07:30AM
Icon agoracom Awakn Life Sciences Receives Regulatory Approval for Flagship Clinic in London to Begin Delivering Treatments

AGORACOM-NR
Mar 17, 2022 07:30AM
New Message